Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | +4.14% | +7.47% | -86.11% |
Apr. 17 | Truist Adjusts Marinus Pharmaceuticals' PT to $10 From $25, Keeps Buy Rating | MT |
Apr. 16 | Baird Downgrades Marinus Pharmaceuticals to Neutral, Price Target at $2 | MT |
Financials (USD)
Sales 2024 * | 41.06M | Sales 2025 * | 62.09M | Capitalization | 82.93M |
---|---|---|---|---|---|
Net income 2024 * | -133M | Net income 2025 * | -93M | EV / Sales 2024 * | 2.02 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.34 x |
P/E ratio 2024 * |
-0.68
x | P/E ratio 2025 * |
-1.15
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.02% |
Latest transcript on Marinus Pharmaceuticals, Inc.
1 day | +4.14% | ||
1 week | +7.47% | ||
Current month | +7.09% | ||
1 month | -82.64% | ||
3 months | -84.87% | ||
6 months | -78.37% | ||
Current year | -86.11% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 21-04-11 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-11-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 08-11-30 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 18-09-04 |
Elan Ezickson
BRD | Director/Board Member | 60 | 19-12-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 11 M€ | -6.03% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 1.51 | +4.14% | 1,620,694 |
24-05-02 | 1.45 | -1.36% | 989,641 |
24-05-01 | 1.47 | +4.26% | 2,304,865 |
24-04-30 | 1.41 | +0.71% | 1,365,206 |
24-04-29 | 1.4 | -0.36% | 930,317 |
Delayed Quote Nasdaq, May 03, 2024 at 04:15 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.11% | 82.93M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- MRNS Stock